1. CDC Guideline for Prescribing Opioids for Chronic Pain — United States, 2016
2. United States Food and Drug Administration.FDA drug safety communication: FDA warns about serious risks and death when combining opioid pain or cough medicines with benzodiazepines; requires its strongest warning. United States Food and Drug Administration Web site. Updated 2016. Accessed July 13 2022.https://www.fda.gov/drugs/drug-safety-and-availability/fda-drug-safety-communication-fda-warns-about-serious-risks-and-death-when-combining-opioid-pain-or
3. Announcement of calendar year (CY) 2020 Medicare advantage capitation rates and Medicare advantage and part D payment policies and final call letter. The Centers for Medicare and Medicaid Services.2019.
4. GiroirB.HHS recommends prescribing or co‐prescribing naloxone to patients at high risk for an opioid overdose. HHS.gov U.S. Department of Health & Human Services Web site. Updated 2018. Accessed July 13 2022.https://public3.pagefreezer.com/browse/HHS.gov/31-12-2020T08:51/https://www.hhs.gov/about/news/2018/12/19/hhs-recommends-prescribing-or-co-prescribing-naloxone-to-patients-at-high-risk-for-an-opioid-overdose.html
5. ViswanathanM KahwatiLC GolinCE et al.Medication Therapy Management Interventions in Outpatient Settings [Internet]. Rockville (MD): Agency for Healthcare Research and Quality (US). 2014. (Comparative Effectiveness Reviews No. 138.) Introduction. Available from:https://www.ncbi.nlm.nih.gov/books/NBK294478/